Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13990159 | 0.80 | L3MBTL1 (0.52) | TP53MAPTALDH1A1MAPK1HSP90AB1 | |
| SCHEMBL27642043 | 0.77 | KMT2A (0.51) | TP53GAARAB9AMAPTALDH1A1 | |
| SCHEMBL574955 | 0.77 | — | — | |
| SCHEMBL22014237 | 0.77 | ADORA3 (0.44) | NPC1TP53GAARAB9AMAPT | |
| SCHEMBL27490700 | 0.77 | TRPA1 (0.49) | TP53GAAALDH1A1CES2CES1 | |
| SCHEMBL1137507 | 0.76 | MAPK1 (0.55) | NPC1TP53RAB9AMAPTALDH1A1 | |
| SCHEMBL259073 | 0.74 | ALDH1A1 (0.52) | NPC1RAB9AMAPTALDH1A1CES2 | |
| SCHEMBL2633244 | 0.72 | SMN1; SMN2 (0.45) | TP53MAPTALDH1A1HSP90AB1HPGD | |
| SCHEMBL1981395 | 0.72 | ALDH1A1 (0.47) | NPC1TP53RAB9AMAPTALDH1A1 | |
| SCHEMBL4249140 | 0.72 | ALDH1A1 (0.64) | TP53MAPTALDH1A1CA9HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0892774-A4 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | ANADYS PHARMACEUTICALS INC (US) | 2001-10-04 | — | — | EP | disclosed |
| US-6239291-B1 | Pyronin antibacterials, process and novel intermediates thereto | SCRIPTGEN PHARMACEUTICALS, INC. | 2001-05-29 | — | — | US | disclosed |
| US-6228882-B1 | MYXOPYRONINS AND CORALLOPYRONINS; RNA POLYMERASE INHIBITORS; SAPONIFICATION, ACIDIFICATION, AZIDING, ACYLATION | ANADYS PHARMACEUTICALS, INC. | 2001-05-08 | — | — | US | disclosed |
| US-6191288-B1 | Pyronin antibacterials, process and novel intermediates thereto | ANADYS PHARMACEUTICALS, INC. | 2001-02-20 | — | — | US | disclosed |
| US-6184393-B1 | MYXOPYRONINS AND CORALLOPYRONINS AS FURAN AND PYRAN- AND SMALL LACTONE-ANTIBIOTICS; INHIBITORS OF RNA POLYMERASE (RNAP) HAVING SELECTIVITY FOR HUMAN RNAP, CELL PENETRATION AND POTENCY AGAINST RIFAMPICIN-RESISTANT STAPH. AUREUS | TRUSTEES OF BOSTON UNIVERSITY | 2001-02-06 | — | — | US | disclosed |
| EP-1043990-A1 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | Scriptgen Pharmaceuticals, Inc. (US) | 2000-10-18 | — | — | EP | disclosed |
| US-6127551-A | 4-HYDROXY-6-ETHYOXYCARBONYLALKENYL-2H-PYRAN-2-ONE IS ACYLATED WITH PROPIONYL CHLORIDE TO FORM A KETONE ADDUCT, FOLLOWED BY BASE-CATALYZED ALDOL TO FROM A PYRONE ALDOL; MESYLATION, FORM A PYRONE KETONE; AND CURTIUS SEQUENCE TO FORM MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| US-6090953-A | PREPARING A MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| WO-2000015626-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR PYRONIN ANTIBACTERIALS | ANADYS PHARMACEUTICALS, INC. (US) | 2000-03-23 | — | — | WO | disclosed |
| US-6022983-A | PREPARING A MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| US-5986111-A | CONDENSATION OF ALDEHYDE WITH PYRONE TO FORM ADDUCT, OXIDATION AND SAPONIFICATION | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999034793-A1 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-07-15 | — | — | WO | disclosed |
| EP-0892774-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-01-27 | — | — | EP | disclosed |
| WO-1997034569-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND INTERMEDIATES | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1997-09-25 | — | — | WO | disclosed |